195 related articles for article (PubMed ID: 38573177)
1. Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades.
Rahman MT; Chaminda Lakmal HH; Hussain J; Jin C
Expert Opin Ther Pat; 2024; 34(1-2):71-81. PubMed ID: 38573177
[TBL] [Abstract][Full Text] [Related]
2. Discovery and Characterization of the First Nonpeptide Antagonists for the Relaxin-3/RXFP3 System.
Gay EA; Guan D; Van Voorhies K; Vasukuttan V; Mathews KM; Besheer J; Jin C
J Med Chem; 2022 Jun; 65(11):7959-7974. PubMed ID: 35594150
[TBL] [Abstract][Full Text] [Related]
3. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration.
DeChristopher B; Park SH; Vong L; Bamford D; Cho HH; Duvadie R; Fedolak A; Hogan C; Honda T; Pandey P; Rozhitskaya O; Su L; Tomlinson E; Wallace I
Bioorg Med Chem Lett; 2019 Apr; 29(8):991-994. PubMed ID: 30824200
[TBL] [Abstract][Full Text] [Related]
5. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ
Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609
[TBL] [Abstract][Full Text] [Related]
6. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
[TBL] [Abstract][Full Text] [Related]
7. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
8. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4.
Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393
[TBL] [Abstract][Full Text] [Related]
9. Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.
Ma S; Smith CM; Blasiak A; Gundlach AL
Br J Pharmacol; 2017 May; 174(10):1034-1048. PubMed ID: 27774604
[TBL] [Abstract][Full Text] [Related]
10. Orthosteric, Allosteric and Biased Signalling at the Relaxin-3 Receptor RXFP3.
Kocan M; Ang SY; Summers RJ
Neurochem Res; 2016 Mar; 41(3):610-9. PubMed ID: 26294284
[TBL] [Abstract][Full Text] [Related]
11. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C
Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868
[TBL] [Abstract][Full Text] [Related]
12. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD
Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442
[TBL] [Abstract][Full Text] [Related]
13. Receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel ligand binding assay for relaxin family peptide receptor 3 and 4 using NanoLuc complementation.
Hu MJ; Shao XX; Li HZ; Nie WH; Wang JH; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2018 Aug; 50(8):1111-1119. PubMed ID: 29770870
[TBL] [Abstract][Full Text] [Related]
15. Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications.
Ganella DE; Ryan PJ; Bathgate RA; Gundlach AL
Behav Pharmacol; 2012 Sep; 23(5-6):516-25. PubMed ID: 22854307
[TBL] [Abstract][Full Text] [Related]
16. Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients.
Lee JH; Koh SQ; Guadagna S; Francis PT; Esiri MM; Chen CP; Wong PT; Dawe GS; Lai MK
Psychopharmacology (Berl); 2016 Feb; 233(4):591-8. PubMed ID: 26542729
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of relaxin-3 and a selective relaxin-3 receptor agonist on food and water intake and hypothalamic neuronal activity in rats.
de Ávila C; Chometton S; Lenglos C; Calvez J; Gundlach AL; Timofeeva E
Behav Brain Res; 2018 Jan; 336():135-144. PubMed ID: 28864207
[TBL] [Abstract][Full Text] [Related]
18. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation.
Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY
FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387
[TBL] [Abstract][Full Text] [Related]
19. Involvement of central relaxin-3 signalling in sodium (salt) appetite.
Smith CM; Walker LL; Chua BE; McKinley MJ; Gundlach AL; Denton DA; Lawrence AJ
Exp Physiol; 2015 Sep; 100(9):1064-72. PubMed ID: 26147879
[TBL] [Abstract][Full Text] [Related]
20. Relaxin-3/RXFP3 system regulates alcohol-seeking.
Ryan PJ; Kastman HE; Krstew EV; Rosengren KJ; Hossain MA; Churilov L; Wade JD; Gundlach AL; Lawrence AJ
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20789-94. PubMed ID: 24297931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]